EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook

Max Lenz iD, Konstantin A Krychtiuk iD, Robert Zilberszac iD, Gottfried Heinz, Julia Riebandt iD, Walter S Speidl

Journal of Clinical Medicine · 20.02.2024 · 13 (5) · 1197

DOI: 10.3390/jcm13051197 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.02.2024. Verfasst von Max Lenz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fulminant myocarditis (FM) constitutes a severe and life-threatening form of acute cardiac injury associated with cardiogenic shock. The condition is characterised by rapidly progressing myocardial inflammation, leading to significant impairment of cardiac function. Due to the acute and severe nature of the disease, affected patients require urgent medical attention to mitigate adverse outcomes. Besides symptom-oriented treatment in specialised intensive care units (ICUs), the necessity for temporary mechanical cardiac support (MCS) may arise. Numerous patients depend on these treatment methods as a bridge to recovery or heart transplantation, while, in certain situations, permanent MCS systems can also be utilised as a long-term treatment option.

Methods

This review consolidates the existing evidence concerning the currently available MCS options. Notably, data on venoarterial extracorporeal membrane oxygenation (VA-ECMO), microaxial flow pump, and ventricular assist device (VAD) implantation are highlighted within the landscape of FM.

Results

Indications for the use of MCS, strategies for ventricular unloading, and suggested weaning approaches are assessed and systematically reviewed.

Conclusions

Besides general recommendations, emphasis is put on the differences in underlying pathomechanisms in FM. Focusing on specific aetiologies, such as lymphocytic-, giant cell-, eosinophilic-, and COVID-19-associated myocarditis, this review delineates the indications and efficacy of MCS strategies in this context.

Schlagwörter

Stichwörter der Autor:innen

ECMOMCSVADfulminant myocarditismechanical circulatory support

Autor:innen und Institutionen

  • Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.
  • Ludwig Boltzmann Institute for Cardiovascular Research, Waehringer Guertel 18-20, 1090 Vienna, Austria.
  • Department of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.

ORCID-Profile: Max Lenz, Konstantin A Krychtiuk, Robert Zilberszac, Julia Riebandt

Zitieren

APA

Lenz, M., Krychtiuk, K. A., Zilberszac, R., Heinz, G., Riebandt, J., & Speidl, W. S. (2024). Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook. Journal of Clinical Medicine, 13(5), 1197. https://doi.org/10.3390/jcm13051197

Vancouver

Lenz M, Krychtiuk KA, Zilberszac R, Heinz G, Riebandt J, Speidl WS. Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook. Journal of Clinical Medicine. 2024;13(5):1197. doi:10.3390/jcm13051197

BibTeX
@article{Lenz2024,
  author = {Lenz, Max and Krychtiuk, Konstantin A and Zilberszac, Robert and Heinz, Gottfried and Riebandt, Julia and Speidl, Walter S},
  title = {Mechanical Circulatory Support Systems in Fulminant Myocarditis: Recent Advances and Outlook},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {5},
  pages = {1197},
  doi = {10.3390/jcm13051197}
}
Kostenlos starten →